Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Jan 9;11(2):180–191. doi: 10.7150/ijms.6283

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited.

PMC Copyright notice

The expression of RXFP2 mRNA in the patellar tendon from ovariectomised rats treated with different sex-steroids: C- control; 0.2E - 0.2μg/kg estrogen; 2E - 2μg/kg estrogen, 20E - 20μg/kg estrogen; 50E -50μg/kg estrogen; P - 4mg progesterone; 125T - 125μg testosterone; 250T - 250μg testosterone, PT-patellar tendon. Data were expressed as mean ± SEM, n=6 per treatment group. * p<0.05 as compared to control, Shapiro-Wilk test,p= 0.842243. An increase in the RXFP1 mRNA was noted following treatment with estrogen at doses exceeding 2μg/kg. Progesterone treatment resulted in the highest increase while testosterone caused a dose-dependent decrease in RXFP2 mRNA expression.